CollPlant Seeks Shareholder Approval for Reverse Split to Restore Nasdaq Compliance

summarizeSummary

CollPlant Biotechnologies has called an extraordinary general meeting for August 18, 2026 to vote on a reverse split aimed at regaining Nasdaq's $1.00 minimum bid price requirement, with the compliance deadline looming on September 21, 2026.

check_boxKey Events · Corporate Governance and Compliance · CLGN

• Reverse Split Vote Called

  Shareholders will vote on August 18, 2026 on a reverse split at a ratio between 1-for-8 and 1-for-12, with the board having discretion to set the exact ratio and effective date.

• Nasdaq Compliance Deadline

  CollPlant received a minimum bid price deficiency notice on March 23, 2026 and has until September 21, 2026 to regain compliance; the stock closed at $0.319 on July 27, 2026.

• Par Value Elimination Proposed

  A second proposal seeks to eliminate the NIS 1.50 par value of ordinary shares, simplifying capital management without changing authorized share count.

• Meeting Logistics

  Record date is July 30, 2026; outstanding shares as of July 27, 2026 were 18,908,207. Proxies must be received by 6:00 a.m. Israel time on August 18, 2026.

auto_awesomeAnalysis · CLGN · Industrial Applications And Services

CollPlant is asking shareholders to approve a reverse split at a ratio between 1-for-8 and 1-for-12, giving the board discretion to set the exact ratio and effective date. The company received a Nasdaq deficiency notice in March 2026 because its stock has traded below $1.00 for 30 consecutive business days. With the compliance deadline of September 21, 2026 approaching and the stock at $0.319, a reverse split is the primary tool to regain compliance and avoid delisting. The meeting is set for August 18, 2026, just over a month before the deadline. A second proposal to eliminate par value is administrative and less impactful. This vote is critical for the company's continued Nasdaq listing.